Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 100MG TABLET Resolved 2019-12-05 2019-12-09 100317
APO-QUETIAPINE 25MG TABLET Resolved 2018-12-27 2020-10-24 70537
APO-QUETIAPINE 25MG TABLET Resolved 2021-04-30 2021-05-31 138352
APO-QUETIAPINE 100MG TABLET Resolved 2021-05-14 2021-05-31 139416
APO-QUETIAPINE 300MG TABLET Resolved 2021-05-14 2021-06-07 139419
APO-QUETIAPINE 100MG TABLET Actual shortage 2021-06-11 2021-08-27 140785
APO-QUETIAPINE 200MG TABLET Actual shortage 2021-06-11 2021-08-27 140788
APO-QUETIAPINE 200MG TABLET Resolved 2021-06-25 2021-08-25 141543
APO-QUETIAPINE 25MG TABLET Actual shortage 2021-08-27 2021-08-27 144776
APO-QUETIAPINE 300MG TABLET Actual shortage 2021-08-27 2021-08-27 144779
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216702
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216705
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-08 2024-01-19 212969
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216687
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-05-31 216690
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216693
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-07-18 216696
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962